Home and security products company Fortune Brands (NYSE:FBIN) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3% year on year to $1.2 billion. Its GAAP profit of $0.83 per share was 13% below analysts’ consensus estimates.
Infrastructure construction company MasTec (NYSE:MTZ) announced better-than-expected revenue in Q2 CY2025, with sales up 19.7% year on year to $3.54 billion. On top of that, next quarter’s revenue guidance ($3.9 billion at the midpoint) was surprisingly good and 5.5% above what analysts were expecting. Its non-GAAP profit of $1.49 per share was 6.4% above analysts’ consensus estimates.
Healthcare services company Select Medical (NYSE:SEM) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 23.9% year on year to $1.34 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.4 billion at the midpoint. Its GAAP profit of $0.32 per share was 13.9% above analysts’ consensus estimates.
Child care and education company Bright Horizons (NYSE:BFAM) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 9.2% year on year to $731.6 million. The company’s full-year revenue guidance of $2.91 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $1.07 per share was 5.8% above analysts’ consensus estimates.
Global life reinsurance provider Reinsurance Group of America (NYSE:RGA) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 9.4% year on year to $5.60 billion. Its non-GAAP profit of $4.72 per share was 15% below analysts’ consensus estimates.
Real estate technology company eXp World (NASDAQ:EXPI) announced better-than-expected revenue in Q2 CY2025, with sales up 1.1% year on year to $1.31 billion. Its GAAP loss of $0.01 per share was significantly below analysts’ consensus estimates.
Internet, cable TV, and phone provider Cable One (NYSE:CABO) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3.4% year on year to $381.1 million. Its GAAP loss of $77.70 per share was significantly below analysts’ consensus estimates.
Consumer products giant Clorox (NYSE:CLX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.5% year on year to $1.99 billion. Its non-GAAP profit of $2.87 per share was 29.7% above analysts’ consensus estimates.
IT services provider DXC Technology (NYSE:DXC) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.4% year on year to $3.16 billion. Guidance for next quarter’s revenue was optimistic at $3.17 billion at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.68 per share was 9.9% above analysts’ consensus estimates.
Outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR) beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 2.2% year on year to $55.25 million. Its non-GAAP loss of $0.03 per share was $0.02 below analysts’ consensus estimates.
Radiation safety company Mirion (NYSE:MIR) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.6% year on year to $222.9 million. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Clothing and footwear retailer Boot Barn (NYSE:BOOT) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 19.1% year on year to $504.1 million. Guidance for next quarter’s revenue was better than expected at $491 million at the midpoint, 1.8% above analysts’ estimates. Its GAAP profit of $1.74 per share was 13.3% above analysts’ consensus estimates.
Electricity generation and hydrogen production company Bloom Energy (NYSE:BE) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.5% year on year to $401.2 million. The company expects the full year’s revenue to be around $1.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.10 per share was significantly above analysts’ consensus estimates.
Manufacturing company Leggett & Platt (NYSE:LEG) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 6.3% year on year to $1.06 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.15 billion at the midpoint. Its non-GAAP profit of $0.30 per share was in line with analysts’ consensus estimates.
